Literature DB >> 21585597

Efficacy of 694-nm Q-switched ruby fractional laser treatment of melasma in female Korean patients.

Woo Sun Jang1, Chang Kyun Lee, Beom Joon Kim, Myeung Nam Kim.   

Abstract

BACKGROUND: Melasma is a common acquired symmetrical hypermelanosis of sun-exposed areas of the skin. Although the classical Q-switched ruby laser (QSRL) has been used successfully for the removal of tattoos and for the treatment of cutaneous pigmented lesions, its efficacy for melasma remains controversial.
OBJECTIVE: We used repeat low-dose fractional QSRL treatment for melasma and analyzed the clinical results.
METHODS: Fifteen Korean women with melasma were enrolled. Each patient received six low-dose fractional QSRL treatments to the face at 2-week intervals. Two investigators independently evaluated Melasma Area and Severity Index (MASI) scores before each session and 4 and 16 weeks after the final session. The intensities of pigmentation and erythema were assessed by measuring skin reflectance using a tristimulus color analyzer.
RESULTS: Mean MASI score decreased from 15.1 ± 3.3 before treatment to 10.6 ± 3.9 16 weeks after the final treatment. The lightness of pigmentation (L-value) increased from 56.6 ± 3.5 before treatment to 59.9 ± 2.8 16 weeks after the final treatment.
CONCLUSIONS: Multiple treatment sessions of low-dose fractional QSRL may be an effective strategy for the treatment of dermal or mixed-type melasma.
© 2011 by the American Society for Dermatologic Surgery, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21585597     DOI: 10.1111/j.1524-4725.2011.02018.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  13 in total

1.  A split-face study: comparison of picosecond alexandrite laser and Q-switched Nd:YAG laser in the treatment of melasma in Asians.

Authors:  Mei-Ching Lee; Ying-Fang Lin; Sindy Hu; Yau-Li Huang; Shyue-Luen Chang; Chun-Yu Cheng; Chun-Shin Chang
Journal:  Lasers Med Sci       Date:  2018-05-07       Impact factor: 3.161

2.  Melasma and laser treatment: an evidenced-based analysis.

Authors:  Shlomit Halachmi; Merete Haedersdal; Moshe Lapidoth
Journal:  Lasers Med Sci       Date:  2013-06-14       Impact factor: 3.161

3.  Q-Switched Laser Combined with Intense Pulsed Laser in the Treatment of Melasma Based on Reflection Confocal Microscope.

Authors:  Jiali Xu; Yijing Pu
Journal:  Comput Math Methods Med       Date:  2022-07-01       Impact factor: 2.809

4.  Efficacy and safety of fractional Q-switched 1064-nm neodymium-doped yttrium aluminum garnet laser in the treatment of melasma in Chinese patients.

Authors:  Baishuang Yue; Qianli Yang; Jinhua Xu; Zhong Lu
Journal:  Lasers Med Sci       Date:  2016-07-23       Impact factor: 3.161

5.  Efficacy of 694-nm fractional Q-switched ruby laser (QSRL) combined with sonophoresis on levorotatory vitamin C for treatment of melasma in Chinese patients.

Authors:  H L Zhou; B Hu; C Zhang
Journal:  Lasers Med Sci       Date:  2016-04-28       Impact factor: 3.161

Review 6.  Confetti-like Sparing: A Diagnostic Clinical Feature of Melasma.

Authors:  Douglas C Wu; Richard E Fitzpatrick; Mitchel P Goldman
Journal:  J Clin Aesthet Dermatol       Date:  2016-02

7.  Lasers are not Effective for Melasma in Darkly Pigmented Skin.

Authors:  Kabir Sardana; Vijay K Garg
Journal:  J Cutan Aesthet Surg       Date:  2014-01

8.  Lasers for treatment of melasma and post-inflammatory hyperpigmentation.

Authors:  Pooja Arora; Rashmi Sarkar; Vijay K Garg; Latika Arya
Journal:  J Cutan Aesthet Surg       Date:  2012-04

9.  Treatment of melasma in Caucasian patients using a novel 694-nm Q-switched ruby fractional laser.

Authors:  Said Hilton; Heike Heise; Bettina Alexandra Buhren; Holger Schrumpf; Edwin Bölke; Peter Arne Gerber
Journal:  Eur J Med Res       Date:  2013-11-14       Impact factor: 2.175

10.  Skin Hyperpigmentation in Indian Population: Insights and Best Practice.

Authors:  Stephanie Nouveau; Divya Agrawal; Malavika Kohli; Francoise Bernerd; Namita Misra; Chitra Shivanand Nayak
Journal:  Indian J Dermatol       Date:  2016 Sep-Oct       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.